Skip header and navigation

Refine By

2 records – page 1 of 1.

Norway's ICT Accessibility Legislation, Methods and Indicators.

https://arctichealth.org/en/permalink/ahliterature291059
Source
Stud Health Technol Inform. 2016; 229:471-81
Publication Type
Journal Article
Date
2016
Author
Malin Rygg
Dagfinn Rømen
Brynhild Runa Sterri
Author Affiliation
Norwegian Authority for Universal Design of ICT, Agency for Public Management and eGovernment (Difi), Norway.
Source
Stud Health Technol Inform. 2016; 229:471-81
Date
2016
Language
English
Publication Type
Journal Article
Keywords
Access to Information - legislation & jurisprudence
Communication
Information Technology - legislation & jurisprudence
Norway
Abstract
This paper gives an overview of the Norwegian legislation on Universal Design of information and communication technology (ICT) and how the Norwegian Authority for Universal Design of ICT works to enforce and achieve the goals behind the legislation. The Authority uses indicators to check websites for compliance with the regulations. This paper describes the rationale and intended use for the indicators and how they are used for both supervision and benchmarks as well as a way of gathering data to give an overview of the current state of Universal Design of websites in Norway.
PubMed ID
27534342 View in PubMed
Less detail

Unlocking Health Canada's cache of trade secrets: mandatory disclosure of clinical trial results.

https://arctichealth.org/en/permalink/ahliterature131803
Source
CMAJ. 2012 Feb 7;184(2):194-9
Publication Type
Article
Date
Feb-7-2012
Author
Matthew Herder
Author Affiliation
Faculty of Medicine, Dalhousie University, Halifax, NS. Matthew.Herder@Dal.ca
Source
CMAJ. 2012 Feb 7;184(2):194-9
Date
Feb-7-2012
Language
English
Publication Type
Article
Keywords
Access to Information - legislation & jurisprudence
Canada
Clinical Trials as Topic - legislation & jurisprudence
Confidentiality - legislation & jurisprudence
Drug Industry - legislation & jurisprudence
Government Agencies - legislation & jurisprudence
Humans
Mandatory Programs - legislation & jurisprudence
Off-Label Use - legislation & jurisprudence
Prescription Drugs - adverse effects
Public Policy - legislation & jurisprudence
Registries
Notes
Cites: CMAJ. 2004 Feb 17;170(4):487-914970096
Cites: Lancet. 2004 Apr 24;363(9418):1341-515110490
Cites: CMAJ. 2004 May 25;170(11):1678-8615159366
Cites: Ann Intern Med. 2004 Sep 21;141(6):477-815355883
Cites: N Engl J Med. 2004 Oct 21;351(17):1707-915470193
Cites: CMAJ. 2011 Jul 12;183(10):1125-621502342
Cites: N Engl J Med. 2008 Jan 17;358(3):252-6018199864
Cites: CMAJ. 2008 Feb 12;178(4):428-3118268270
Cites: Curr Med Res Opin. 2008 Jun;24(6):1683-918462565
Cites: PLoS Med. 2008 Nov 25;5(11):e217; discussion e21719067477
Cites: BMJ. 2011;342:d257021511787
Cites: BMJ. 2005 Apr 23;330(7497):956-815845980
PubMed ID
21876028 View in PubMed
Less detail